Company intelligence
OMERACT (Outcome Measures in Rheumatology)
Committed to Collaborative International Clinical Outcomes Research Excellence in the field of Rheumatology since 1992
About OMERACT (Outcome Measures in Rheumatology)
OMERACT is a global, volunteer-driven, not for profit organization committed to improving outcomes for patients with autoimmune and musculoskeletal diseases through advancing the design and quality of clinical studies. Through rigorous methodology and our global Working Groups, OMERACT supports the development of Core Outcome Sets (COS), identifying patient and disease-relevant areas to be measured (domains) and the corresponding measurement instruments for use in clinical trials, including those for regulatory approval of new treatments.
Verified activity
Signals from OMERACT (Outcome Measures in Rheumatology)
6 published signals
Research & Knowledge
OMERACT (Outcome Measures in Rheumatology) published a 2026 study of GLP-1 agonists in SLE and lupus patients with diabetes showing fewer flares, lower risk of lupus nephritis, and fewer strokes.
Reported by Donald Thomas
Presence & Recognition
OMERACT (Outcome Measures in Rheumatology) employee Dr. Esen K. Akpek is featured as an Sjogren's advocate, clinician, and researcher.
Reported by Donald Thomas
Presence & Recognition
OMERACT (Outcome Measures in Rheumatology) accepted an abstract for the American College of Rheumatology at Orlando Convergence #ACR26 regarding how lupus patients receive non-lupus diseases before diagnosis and how some persist using a large US database.
Reported by Donald Thomas
Research & Knowledge
OMERACT (Outcome Measures in Rheumatology) published a paper titled Clinical Validation of a Refined Lupus Disease Activity Index Informed by Immune Mediators that Characterizes Clinical and Serological Disease Activity In Systemic Lupus Erythematosus in the American College of Rheumatology for Convergence Orlando #ACR26
Reported by Donald Thomas
Presence & Recognition
OMERACT (Outcome Measures in Rheumatology) accepted an abstract poster for the American College of Rheumatology at Convergence Orlando #ACR26 on Sjogrens patients and monitoring.
Reported by Donald Thomas
Presence & Recognition
OMERACT (Outcome Measures in Rheumatology) authors Dr. Shivani Garg, Caroline Packee, and co-authors accepted to present an abstract poster at American College of Rheumatology at Convergence Orlando #ACR26.
Reported by Donald Thomas